These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 6213940)

  • 1. Dehydroepiandrosterone: an anti-obesity and anti-carcinogenic agent.
    Schwartz AG; Hard GC; Pashko LL; Abou-Gharbia M; Swern D
    Nutr Cancer; 1981; 3(1):46-53. PubMed ID: 6213940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of spontaneous breast cancer formation in female C3H(Avy/a) mice by long-term treatment with dehydroepiandrosterone.
    Schwartz AG
    Cancer Res; 1979 Mar; 39(3):1129-32. PubMed ID: 154968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of dehydroepiandrosterone (DHEA) and its metabolites in obese-hyperglycemic mutant mice.
    Coleman DL
    Prog Clin Biol Res; 1988; 265():161-75. PubMed ID: 2970093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenalectomy and steroid treatment in obese (ob/ob) and diabetic (db/db) mice.
    Shimomura Y; Bray GA; Lee M
    Horm Metab Res; 1987 Jul; 19(7):295-9. PubMed ID: 2957297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dehydroepiandrosterone on obesity and glucose-6-phosphate dehydrogenase activity in the lethal yellow mouse (strain 129/Sv-Ay/Aw).
    Granholm NH; Staber LD; Wilkin PJ
    J Exp Zool; 1987 Apr; 242(1):67-74. PubMed ID: 2955075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydroepiandrosterone intake protects against 7,12-dimethylbenz(a)anthracene-induced mammary tumor development in the obese Zucker rat model.
    Hakkak R; Shaaf S; Jo CH; MacLeod S; Korourian S
    Oncol Rep; 2010 Aug; 24(2):357-62. PubMed ID: 20596621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of DNA synthesis in mouse epidermis and breast epithelium by dehydroepiandrosterone and related steroids.
    Pashko LL; Schwartz AG; Abou-Gharbia M; Swern D
    Carcinogenesis; 1981; 2(8):717-21. PubMed ID: 6456847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone.
    Ratko TA; Detrisac CJ; Mehta RG; Kelloff GJ; Moon RC
    Cancer Res; 1991 Jan; 51(2):481-6. PubMed ID: 1824682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of obesity in Avy/a mice by dehydroepiandrosterone.
    Yen TT; Allan JA; Pearson DV; Acton JM; Greenberg MM
    Lipids; 1977 May; 12(5):409-13. PubMed ID: 140989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation into the effect of DHEA on renal carcinogenesis induced in the rat by a single dose of DMN.
    Ogiu T; Hard GC; Schwartz AG; Magee PN
    Nutr Cancer; 1990; 14(1):57-67. PubMed ID: 2142277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accelerated appearance of chemically induced mammary carcinomas in obese yellow (Avy/A) (BALB/c X VY) F1 hybrid mice.
    Wolff GL; Kodell RL; Cameron AM; Medina D
    J Toxicol Environ Health; 1982 Jul; 10(1):131-42. PubMed ID: 6290678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selenium and low levels of lead on mammary tumor development and growth in MMTV-infected female mice.
    Schrauzer GN
    Biol Trace Elem Res; 2008 Dec; 125(3):268-75. PubMed ID: 18726561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The estrogen antagonist EM-652 and dehydroepiandrosterone prevent diet- and ovariectomy-induced obesity.
    Lemieux C; Picard F; Labrie F; Richard D; Deshaies Y
    Obes Res; 2003 Mar; 11(3):477-90. PubMed ID: 12634448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel dehydroepiandrosterone analogues with enhanced biological activity and reduced side effects in mice and rats.
    Schwartz AG; Lewbart ML; Pashko LL
    Cancer Res; 1988 Sep; 48(17):4817-22. PubMed ID: 2970293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DHEA: "miracle" drug?
    Kent S
    Geriatrics; 1982 Sep; 37(9):157-8, 161. PubMed ID: 6213449
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylaxis of spontaneously developing mammary carcinoma in C3H-HeJ female mice by suppression of prolactin.
    Welsch CW; Gribler C
    Cancer Res; 1973 Nov; 33(11):2939-46. PubMed ID: 4795906
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of retinyl acetate on the incidence of mammary carcinomas and hepatomas in mice.
    Maiorana A; Gullino PM
    J Natl Cancer Inst; 1980 Mar; 64(3):655-63. PubMed ID: 6928249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocarcinogenicity of dehydroepiandrosterone in the rat.
    Rao MS; Subbarao V; Yeldandi AV; Reddy JK
    Cancer Res; 1992 May; 52(10):2977-9. PubMed ID: 1316232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.